Single dose of inducible nitric oxide synthase inhibitor induces prolonged inflammatory cell accumulation and fibrosis around injured tendon and synovium

Mediators of Inflammation

Volumn 13, Issue 3, 2004, Pages 157-164

  Darmani, Homa ^a   Crossan, James C ^b   Curtis, Adam ^c  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b WESTERN INFIRMARY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adhesion; Crush injury; Fibrosis; Nitric oxide; Tendon

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CRUSH TRAUMA; DISEASE COURSE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FIBROSIS; FLEXOR TENDON; FLEXOR TENDON INJURY; HISTOPATHOLOGY; INFLAMMATORY CELL; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SUBCUTANEOUS TISSUE; SYNOVITIS; TENDON; WOUND HEALING;

ADHESIONS; ANIMALS; ANTI-INFLAMMATORY AGENTS; INFLAMMATION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; SYNOVITIS; TENDON INJURIES; WOUND HEALING;

ANIMALIA; RATTUS NORVEGICUS;

EID: 4143057064     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09511920410001713556     Document Type: Article

References (22)

1. Chang J, Thunder R, Most D, Longaker MT, Lineaweaver WC. Studies in flexor tendon wound healing: neutralizing antibody to TGF-β1 increases postoperative range of motion. Plast Reconstr Surg 2000; 105: 148-155.
2. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
3. Chang J, Most D, Stelnicki E, et al. Gene expression of transforming growth factor beta-1 in rabbit zone II flexor tendon wound healing: Evidence for dual mechanisms of repair. Plast Reconstr Surg 1997; 100: 937-944.
4. Miyajima A, Chen J, Lawrence C, et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 2000; 58: 2301-2313.
5. Brahmatewari J, Serafini A, Serralta V, Mertz PM, Eaglstein WH. The effects of topical transforming growth factor-beta2 and anti-transforming growth factor-beta2,3 on scarring in pigs. J Cutan Med Surg 2000; 4: 126-131.
6. Gilbert RS, Herschman HR. Transforming growth factor beta differentially modulates the inducible NOS gene in distinct cell types. Biochem Biophys Res Commun 1993; 195: 380-384.
7. Kunz D, Walker G, Pfeilschifter J. Transforming growth factor-beta 2 inhibits interleukin 1 beta-induced expression of inducible NOS in rat renal mesangial cells. Inflamm Res 1997; 46: 327-331.
8. Knowles RG, Moncada S. NO synthases in mammals. Biochem J 1994; 298: 249-258.
9. Lirk P, Hoffmann G, Rieder J. Inducible nitric oxide synthase-time for reappraisal. Curr Drug Targets Inflamm Allergy 2002; 1: 89-108.
10. Shi HP, Most D, Efron DT, Tantry U, Fischel MH, Barbul A. The role of iNOS in wound healing. Surgery 2001; 130: 225-229.
11. Schwentker A, Billiar TR. NO and wound repair. Surg Clin North Am 2003; 83: 521-530.
12. Ferrini MG, Vernet D, Magee TR, et al. Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide 2002; 6: 283-294.
13. Lin JH, Wang MX, Wei A, Zhu W, Diwan AD, Murrell GA. Temporal expression of nitric oxide synthase isoforms in healing Achilles tendon. J Orthop Res 2001; 19: 136-142.
14. Albina JE, Mills CD, Barbul A, et al. Arginine metabolism in wounds. Am J Physiol 1988; 17: E459-E467.
15. De Caterina R, Libby P, Peng H-B, et al. Nitric oxide decreases cytokine induced endothelial activation. NO selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-68.
16. Liu P, Yin K, Nagele R, Wong PY-K. Inhibition of NOS attenuates peroxynitrite generation, but augments neutrophil infiltration in hepatic ischemia-reperfusion. J Pharmacol Exp Ther 1998; 284: 1139-1146.
17. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995; 146: 56-66.
18. Beck LS, DeGuzman L, Lee WP, Xu Y, Siegel MW, Amento EP. One systemic administration of TGF- beta 1 reverses age- or glutocorticoid-impaired wound healing. J Clin Invest 1993; 92: 2841-2849.
19. Hou J, Kato H, Cohen RA, Chobanian AV, Brecher P. Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase. J Clin Invest 1995; 96: 2469-2477.
20. Warren JS, Ward PA, Johnson KJ. Oxygen radicals as mediators of inflammation. In: Henson PM, Murphy RC, eds. Handbook of Inflammation, Vol 6: Mediators of the Inflammatory Process. Amsterdam: Elsevier/Science Publishers, 1989.
21. Qasim FJ, Mathieson PW, Sendo F, Thiru S, Oliveira DB. Role of neutrophils in the pathogenesis of experimental vasculitis. Am J Pathol 1996; 149: 81-89.
22. Secco DD, Paron JA, de Oliveira SH, Ferreira SH, Silva JS, Cunha F, de Q. Neutrophil migration in inflammation: nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide 2003; 9: 153-164.